{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:19Z","timestamp":1762867099764,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.medmal.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T03:30:28Z","timestamp":1492054228000},"page":"382-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of high-priced systemic antifungal prescriptions"],"prefix":"10.1016","volume":"47","author":[{"given":"C.","family":"Poulat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nivoix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Launoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lutun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-L.","family":"Woehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lev\u00eaque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gourieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2017.03.004_bib0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejcsup.2007.06.007","article-title":"Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients","volume":"Suppl.\u00a05","author":"Herbrecht","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.medmal.2017.03.004_bib0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejcsup.2007.06.005","article-title":"Empirical antifungal therapy in neutropaenic cancer patients with persistent fever","volume":"5","author":"Marchetti","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.medmal.2017.03.004_bib0105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u00a0\u2013\u00a02009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 7","key":"10.1016\/j.medmal.2017.03.004_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect Dec"},{"issue":"Suppl 7","key":"10.1016\/j.medmal.2017.03.004_bib0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect Dec"},{"issue":"Suppl 7","key":"10.1016\/j.medmal.2017.03.004_bib0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1469-0691.12042","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS","volume":"18","author":"Lortholary","year":"2012","journal-title":"Clin Microbiol Infect Dec"},{"key":"10.1016\/j.medmal.2017.03.004_bib0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.03.004_bib0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.03.004_bib0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"15","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.03.004_bib0140","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/jac\/dks256","article-title":"Adherence to recommendations for the use of antifungal agents in a tertiary care hospital","volume":"67","author":"Nivoix","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.03.004_bib0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diagmicrobio.2004.12.010","article-title":"Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines","volume":"52","author":"Patel","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2017.03.004_bib0150","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/jac\/dkq240","article-title":"Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study)","volume":"65","author":"Pagano L1","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.03.004_bib0155","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"COMIC Study Group (Collaborative Group on Mycoses). Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"Valerio","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.03.004_bib0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1469-0691.2012.03891.x","article-title":"A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital","volume":"19","author":"L\u00f3pez-Medrano F1","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.medmal.2017.03.004_bib0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","article-title":"Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. AmarCAND2 study group","volume":"6","author":"Leroy","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"7","key":"10.1016\/j.medmal.2017.03.004_bib0170","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.medmal.2017.03.004_bib0175","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/jac\/dkr244","article-title":"Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes","volume":"66","author":"Shah","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.medmal.2017.03.004_bib0180","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00134-015-4053-1","article-title":"Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post-hoc analyses of the AmarCAND2 study data","volume":"41","author":"Bailly","year":"2015","journal-title":"Intensive Care Med"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17301476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17301476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:14:55Z","timestamp":1759972495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X17301476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0399077X17301476"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2017.03.004","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of high-priced systemic antifungal prescriptions","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}